Fri, March 7, 2025
[ Fri, Mar 07th 2025 ]: WOPRAI
As of Mar 07th, 2025, there has been substantial selling of CareCloud, Inc. in recent trading
[ Fri, Mar 07th 2025 ]: WOPRAI
As of Mar 07th, 2025, there has been substantial .. dical Technology Holdings, Inc. in recent trading
[ Fri, Mar 07th 2025 ]: WOPRAI
As of Mar 07th, 2025, there has been substantial .. ing of CHORD ENERGY CORPORATION in recent trading
[ Fri, Mar 07th 2025 ]: WOPRAI
As of Mar 07th, 2025, there has been substantial .. Alpha Technology Group Limited in recent trading
[ Fri, Mar 07th 2025 ]: WOPRAI
As of Mar 07th, 2025, there has been substantial selling of Ayr Wellness Inc. in recent trading
[ Fri, Mar 07th 2025 ]: WOPRAI
As of Mar 07th, 2025, there has been substantial selling of Vicinity Centres in recent trading
[ Fri, Mar 07th 2025 ]: WOPRAI
As of Mar 07th, 2025, there has been substantial .. en Planet Bioengineering Co Ltd in recent trading
[ Fri, Mar 07th 2025 ]: WOPRAI
As of Mar 07th, 2025, there has been substantial selling of in recent trading
[ Fri, Mar 07th 2025 ]: WOPRAI
75 Earnings Releases for Mar 07th, 2025
[ Fri, Mar 07th 2025 ]: MSN
Building a Real Estate Portfolio: Strategies for Millennial CEOs
Thu, March 6, 2025
[ Thu, Mar 06th 2025 ]: GOBankingRates
What to Do with Money Sitting in the Bank: Top Options for 2025
[ Thu, Mar 06th 2025 ]: Mint
Stocks to buy today: Ankush Bajaj recommends three stocks for 7 March
[ Thu, Mar 06th 2025 ]: CNN
US stocks slide and Nasdaq enters correction as chaos over Trump's tariffs intensifies
[ Thu, Mar 06th 2025 ]: MSN
Potbelly (NASDAQ:PBPB) Reports Q4 In Line With Expectations But Stock Drops
[ Thu, Mar 06th 2025 ]: Investopedia
S&P 500 Gains and Losses Today: AI Stocks Fall After Soft Outlook From Marvell Technology
[ Thu, Mar 06th 2025 ]: TipRanks
Coca-Cola Europacific Partners price target raised to $98 from $92 at Barclays
[ Thu, Mar 06th 2025 ]: Bankrate
5 sure-fire signs of a stock market bubble
[ Thu, Mar 06th 2025 ]: Insider
Sorry American firms, the AI trade has moved to China
[ Thu, Mar 06th 2025 ]: AOL
Should you tap your home equity to invest?
[ Thu, Mar 06th 2025 ]: MarketWatch
'I'm deeply disturbed': My portfolio lost 20%. Wi .. mp's trade war, do I sell my stocks and buy gold?
[ Thu, Mar 06th 2025 ]: MarketWatch
Stock market faces a critical day with Friday's high-stakes jobs report and a Powell speech
[ Thu, Mar 06th 2025 ]: Mint
India's oldest index fund completes 25 years
[ Thu, Mar 06th 2025 ]: Barchart
Is Arista Networks Stock Outperforming the Nasdaq?
[ Thu, Mar 06th 2025 ]: GOBankingRates
How Rich You'd Be If You Invested $1,000 in These 5 Major Companies 10 Years Ago
[ Thu, Mar 06th 2025 ]: MoneyWeek
Can European stock markets continue their rally?
[ Thu, Mar 06th 2025 ]: Money
Scared of Stock Market Swings? Don't Cash Out
[ Thu, Mar 06th 2025 ]: Barchart
How Is Gilead Sciences' Stock Performance Compared to Other Pharmaceutical Stocks?
[ Thu, Mar 06th 2025 ]: MoneyWeek
Investors pull more money from UK equities - but is a turnaround on the horizon?
[ Thu, Mar 06th 2025 ]: MarketWatch
Friday could be a critical day for investors, with a high-stakes jobs report and a Powell speech
[ Thu, Mar 06th 2025 ]: Barchart
Stocks Tumble on Higher Bond Yields and Chip Stock Weakness
[ Thu, Mar 06th 2025 ]: Forbes
The Disruption Of AI In Stock Markets: A New Era Of Investment Decisions And Automation
[ Thu, Mar 06th 2025 ]: MarketBeat
Eli Lilly Pours $27B Into U.S. Growth-What It Means for Investors
[ Thu, Mar 06th 2025 ]: cnbctv18
Family offices are increasingly investing via AIFs: What's driving the trend
[ Thu, Mar 06th 2025 ]: Fintel
Stifel Downgrades Global Partners LP - Preferred Stock (GLP.PRB)
[ Thu, Mar 06th 2025 ]: MarketWatch
I'm 69 and only have $121,000 in my 401(k). How can I repair the damage of the past?
[ Thu, Mar 06th 2025 ]: MarketWatch
'I live a very simple life but I need help.' I'm .. in Social Security. But I want to leave a legacy
[ Thu, Mar 06th 2025 ]: Mint
How to navigate the rollercoaster ride on Dalal S .. are 6 strategies to beat stock market volatility
[ Thu, Mar 06th 2025 ]: Reuters
Investors question 'Trump put' as tariffs rattle stock markets
[ Thu, Mar 06th 2025 ]: Fortune
Warren Buffett acts like the U.S. stock market is in bubble territory. He might be onto something
[ Thu, Mar 06th 2025 ]: WOPRAI
As of Mar 06th, 2025, there has been substantial .. f American Pacific Mining Corp. in recent trading
[ Thu, Mar 06th 2025 ]: WOPRAI
As of Mar 06th, 2025, there has been substantial .. ling of Organovo Holdings, Inc. in recent trading
[ Thu, Mar 06th 2025 ]: WOPRAI
As of Mar 06th, 2025, there has been substantial .. Dragonfly Energy Holdings Corp. in recent trading
[ Thu, Mar 06th 2025 ]: WOPRAI
As of Mar 06th, 2025, there has been substantial .. ing of Bon Natural Life Limited in recent trading
[ Thu, Mar 06th 2025 ]: WOPRAI
As of Mar 06th, 2025, there has been substantial .. awson Infrastructure Group Inc. in recent trading
[ Thu, Mar 06th 2025 ]: WOPRAI
As of Mar 06th, 2025, there has been substantial selling of Minim, Inc. in recent trading
[ Thu, Mar 06th 2025 ]: WOPRAI
As of Mar 06th, 2025, there has been substantial selling of PHH Corporation in recent trading
[ Thu, Mar 06th 2025 ]: WOPRAI
As of Mar 06th, 2025, there has been substantial .. Daiichi Sankyo Company, Limited in recent trading
[ Thu, Mar 06th 2025 ]: WOPRAI
As of Mar 06th, 2025, there has been substantial .. SolarWindow Technologies, Inc. in recent trading

How Is Gilead Sciences' Stock Performance Compared to Other Pharmaceutical Stocks?

Valued at a market cap of $143.8 billion, Gilead Sciences, Inc. (GILD) is a biopharmaceutical company that discovers, develops, and commercializes medicines in the areas of unmet medical need. The Foster City,
Gilead Sciences, Inc. has shown a year-to-date increase of about 10.1% in its stock value, which is slightly below the average performance of other stocks in the Medical - Biomedical and Genetics industry, which have risen by approximately 10.5%. Over the past six months, Gilead's stock has risen by 1.3%, while the industry average was a 1.6% increase. This indicates that Gilead is performing comparably but not outperforming its peers. The article also discusses broader market trends, noting that the S&P 500 has gained about 17.6% year-to-date, highlighting that the pharmaceutical sector, including Gilead, has not kept pace with the general market's growth. Additionally, the article provides insights into Gilead's financial health, mentioning its revenue growth and profitability metrics, which are crucial for investors considering the stock's future potential.

Read the Full Barchart Article at:
[ https://www.msn.com/en-us/money/savingandinvesting/how-is-gilead-sciences-stock-performance-compared-to-other-pharmaceutical-stocks/ar-AA1AnJd3 ]